Suppr超能文献

1级和2级腰椎全椎间盘置换术后的临床结果:1187例患者随访7至21年

Clinical Outcomes After 1 and 2-Level Lumbar Total Disc Arthroplasty: 1,187 Patients with 7 to 21-Year Follow-up.

作者信息

Marnay Thierry P, Geneste Guillaume Y, Edgard-Rosa Gregory W, Grau-Ortiz Martin M, Hirsch Caroline C, Negre Georges G

机构信息

Montpellier Spine Institute (CCV) Clinique du Parc, Castelnau-le-Lez, France.

出版信息

J Bone Joint Surg Am. 2025 Jan 1;107(1):53-65. doi: 10.2106/JBJS.23.00735. Epub 2024 Nov 22.

Abstract

BACKGROUND

In this study, we expand the supportive evidence for total disc arthroplasty (TDA) with results up to 21 years in a large patient cohort who received a semiconstrained ball-and-socket lumbar prosthesis. The objectives of the study were to compare the results for 1 versus 2-level surgeries and to evaluate whether prior surgery at the index level(s) impacts clinical outcomes.

METHODS

From 1999 to 2013, 1,187 patients with chronic lumbar degenerative disc disease (DDD) underwent lumbar TDA, of whom 772 underwent a 1-level procedure and 415 underwent a 2-level procedure. A total of 373 (31.4%) of the 1,187 patients had prior index-level surgery. Patients were evaluated preoperatively; at 3, 6, 12, 18, and 24 months postoperatively; and yearly thereafter. The follow-up duration ranged from 7 to 21 years (mean, 11 years and 8 months). Collected data included radiographic, neurological, and physical assessments, as well as self-evaluations using the Oswestry Disability Index (ODI) and visual analog scale (VAS) for back and leg pain. Perioperative data points, complication rates, and reoperation or revision rates were also assessed. Patients were divided into 4 groups: 1-level TDA with no prior surgery at the index level, 1-level TDA with prior surgery, 2-level TDA with no prior surgery, and 2-level TDA with prior surgery.

RESULTS

All groups showed dramatic reduction in the ODI at 3 months postoperatively and maintained these scores over time. Although VAS pain did not diminish to its final level as rapidly for patients with prior surgery, there was no significant difference between the groups in terms of pain reduction at 24 months postoperatively. Of 1,187 patients, 49 (4.13%) required either a new surgery at another level or revision or reoperation at the index level. Rates were too low in all groups to compare them statistically. Total TDA revision and adjacent-level surgery rates over 7 to 21 years were very low (0.67% and 1.85%, respectively).

CONCLUSIONS

This study demonstrates the robust long-term clinical success of 1 and 2-level lumbar TDA as assessed at 7 to 21 years postoperatively in one of the largest evaluated cohorts of patients with TDA. Patients had dramatic and maintained reductions in disability and pain scores over time and low rates of index-level revision or reoperation and adjacent-level surgery relative to published long-term fusion data. Additionally, patients who underwent 1-level lumbar TDA and those who underwent 2-level TDA demonstrated equivalent improvement, as did patients with prior surgery at the index level and those with no prior surgery.

LEVEL OF EVIDENCE

Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

摘要

背景

在本研究中,我们通过对接受半限制球窝式腰椎假体的大型患者队列长达21年的随访结果,扩充了全椎间盘置换术(TDA)的支持性证据。本研究的目的是比较单节段与双节段手术的结果,并评估索引节段先前的手术是否会影响临床疗效。

方法

1999年至2013年,1187例慢性腰椎退行性椎间盘疾病(DDD)患者接受了腰椎TDA,其中772例行单节段手术,415例行双节段手术。1187例患者中共有373例(31.4%)在索引节段有过先前手术。对患者进行术前评估;术后3、6、12、18和24个月进行评估;此后每年评估一次。随访时间为7至21年(平均11年8个月)。收集的数据包括影像学、神经学和体格检查评估,以及使用Oswestry功能障碍指数(ODI)和视觉模拟量表(VAS)对腰腿痛进行的自我评估。还评估了围手术期数据点、并发症发生率以及再次手术或翻修率。患者分为4组:索引节段无先前手术的单节段TDA组、索引节段有先前手术的单节段TDA组、索引节段无先前手术的双节段TDA组和索引节段有先前手术的双节段TDA组。

结果

所有组在术后3个月时ODI均显著降低,并随时间维持这些分数。尽管先前手术患者的VAS疼痛没有那么快降至最终水平,但术后24个月时各组在疼痛减轻方面没有显著差异。1187例患者中,49例(4.13%)需要在其他节段进行新的手术,或在索引节段进行翻修或再次手术。所有组的发生率都很低,无法进行统计学比较。7至21年期间的全TDA翻修率和相邻节段手术率非常低(分别为0.67%和1.85%)。

结论

本研究表明,在接受评估的最大TDA患者队列之一中,术后7至21年评估显示,单节段和双节段腰椎TDA在临床上取得了稳健的长期成功。随着时间的推移,患者的功能障碍和疼痛评分显著降低且维持在较低水平,与已发表的长期融合数据相比,索引节段翻修或再次手术以及相邻节段手术的发生率较低。此外,接受单节段腰椎TDA的患者和接受双节段TDA的患者改善情况相当,索引节段有先前手术的患者和无先前手术的患者也是如此。

证据水平

治疗性III级。有关证据水平的完整描述,请参阅作者指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c35c/11665976/d71462fee510/jbjsam-107-53-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验